1. Home
  2. CCCC vs UIS Comparison

CCCC vs UIS Comparison

Compare CCCC & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • UIS
  • Stock Information
  • Founded
  • CCCC 2015
  • UIS 1942
  • Country
  • CCCC United States
  • UIS United States
  • Employees
  • CCCC N/A
  • UIS N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • UIS EDP Services
  • Sector
  • CCCC Health Care
  • UIS Technology
  • Exchange
  • CCCC Nasdaq
  • UIS Nasdaq
  • Market Cap
  • CCCC 304.8M
  • UIS 294.9M
  • IPO Year
  • CCCC 2020
  • UIS N/A
  • Fundamental
  • Price
  • CCCC $6.86
  • UIS $4.78
  • Analyst Decision
  • CCCC Buy
  • UIS
  • Analyst Count
  • CCCC 7
  • UIS 0
  • Target Price
  • CCCC $8.71
  • UIS N/A
  • AVG Volume (30 Days)
  • CCCC 2.4M
  • UIS 414.3K
  • Earning Date
  • CCCC 08-06-2024
  • UIS 07-30-2024
  • Dividend Yield
  • CCCC N/A
  • UIS N/A
  • EPS Growth
  • CCCC N/A
  • UIS N/A
  • EPS
  • CCCC N/A
  • UIS N/A
  • Revenue
  • CCCC $20,036,000.00
  • UIS $1,986,800,000.00
  • Revenue This Year
  • CCCC $26.24
  • UIS $0.77
  • Revenue Next Year
  • CCCC N/A
  • UIS $3.15
  • P/E Ratio
  • CCCC N/A
  • UIS N/A
  • Revenue Growth
  • CCCC N/A
  • UIS N/A
  • 52 Week Low
  • CCCC $1.06
  • UIS $2.60
  • 52 Week High
  • CCCC $11.88
  • UIS $8.12
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 70.41
  • UIS 61.63
  • Support Level
  • CCCC $4.36
  • UIS $4.21
  • Resistance Level
  • CCCC $7.66
  • UIS $4.50
  • Average True Range (ATR)
  • CCCC 0.51
  • UIS 0.15
  • MACD
  • CCCC 0.33
  • UIS 0.09
  • Stochastic Oscillator
  • CCCC 75.79
  • UIS 87.70

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.

Share on Social Networks: